Sublocade Treatment for Persistent Opioid Cravings

Opioid cravings may not disappear immediately after starting Sublocade. Buprenorphine is designed to reduce cravings and withdrawal symptoms, but individual response can vary depending on opioid use history, prior buprenorphine exposure, severity of opioid use disorder, and the stage of treatment.

Persistent cravings can also indicate that a patient’s current treatment plan needs further evaluation. Current prescribing information allows clinicians to consider a higher monthly maintenance dose in patients who tolerate Sublocade but do not have a satisfactory clinical response.

At Ascension Solutions Treatment, our clinical team monitors craving intensity, withdrawal symptoms, medication response, and overall recovery progress after Sublocade begins. These assessments help determine whether changes in dosing, follow-up care, or additional recovery support may be appropriate.

Some patients may notice breakthrough cravings between Sublocade injections, but increased cravings near the end of the dosing interval should not automatically be assumed to mean that the medication has “worn off.” Sublocade is formulated to provide extended buprenorphine exposure, and maintenance injections are generally administered at least 26 days apart.

If cravings become more noticeable before the next scheduled injection, the patient’s clinical response should be reviewed. Factors such as treatment stage, opioid exposure, stressors, withdrawal symptoms, and current dose may influence how well cravings are controlled. The prescribing information allows dose adjustment when clinical response to maintenance treatment is inadequate.

At Ascension Solutions Treatment, our team encourages patients to discuss changes in cravings rather than adjusting treatment on their own. Ongoing evaluation helps determine whether the current Sublocade schedule and dose remain appropriate for the patient’s opioid use disorder treatment needs.

Patients should contact their doctor when opioid cravings become persistent, noticeably stronger, difficult to manage, or begin interfering with their ability to remain engaged in treatment. Breakthrough cravings may indicate that additional assessment is needed to understand whether medication response or other recovery-related factors have changed.

Patients should also seek clinical guidance if cravings occur alongside worsening withdrawal symptoms, renewed opioid use, significant medication side effects, or concerns about their ability to avoid opioid use. Buprenorphine treatment is intended to reduce physiological cravings and withdrawal symptoms, so changes in these symptoms deserve appropriate evaluation.

At Ascension Solutions Treatment, our clinical team can reassess Sublocade response, symptom patterns, current dosing, and other factors affecting recovery. Early communication allows the treatment plan to be reviewed and modified when clinically appropriate rather than waiting for cravings to become more difficult to manage.

Counseling can complement Sublocade by addressing behavioral and emotional factors that medication alone may not fully resolve. While buprenorphine helps manage the physical aspects of opioid use disorder, counseling can help patients identify situations, emotions, and patterns that trigger cravings and develop practical strategies for responding to them.

Behavioral support may also help patients strengthen coping skills, improve stress management, work through relationship or lifestyle challenges, and develop strategies for reducing the likelihood of returning to opioid use. SAMHSA describes medication combined with counseling and behavioral therapies as a whole-person approach to substance use disorder treatment.

At Ascension Solutions Treatment, our team can incorporate appropriate counseling and recovery support alongside Sublocade treatment based on each patient’s individual needs. Combining medication management with behavioral support can help patients better understand their cravings and build skills that support continued recovery.

Dr. Jonathan Hall, MD, and the team at Ascension Solutions Treatment address persistent opioid cravings with Sublocade by reviewing each patient’s current buprenorphine treatment, craving patterns, withdrawal symptoms, medication response, and overall recovery progress. Sublocade provides extended-release buprenorphine through a monthly injection, which can help maintain steady medication exposure and reduce the need for daily dosing. Our team uses ongoing clinical assessments to determine whether the current treatment approach is adequately controlling cravings.

If cravings continue or become more difficult to manage, Dr. Jonathan Hall, MD, and our team reassess factors such as treatment response, dosing needs, recent opioid use, stressors, and other recovery challenges. Ascension Solutions Treatment may adjust the care plan when clinically appropriate and can incorporate additional counseling or behavioral support to help patients manage triggers and strengthen long-term recovery from opioid use disorder.

For more information, contact us or request an appointment online. We are conveniently located at 3780 Holcomb Bridge Road Suite D2, Peachtree Corners, GA 30092. We serve patients from Peachtree Corners GA, Asheville NC, Swannanoa NC, Johns Creek GA, Woodfin NC, Biltmore Forest NC, Fairview NC, Roswell GA, Dunwoody GA, Pittsburg GA, Western North Carolina, and the surrounding areas.